USX:APLS - Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts
• Options

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2014 Q2	2014 Q3	2014 Q4	2015 Q2	2015 Q3	2015 Q4	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	623K -	5.65M 806.9%	60.29M 967.1%	14.38M -76.1%	16.32M 13.5%	22.06M 35.1%	22.66M 2.8%	44.85M 97.9%	94.97M 111.8%	110.4M 16.2%	146.38M 32.6%	172.32M 17.7%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0 -	149K -	5.05M 3289.9%	1.25M -75.3%	82K -93.4%	1.38M 1584.1%	2.92M 111.8%	7.81M 167.0%	8.38M 7.3%	22.41M 167.5%	19.91M -11.1%	20.21M 1.5%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	623K -	5.5M 783.0%	55.24M 904.2%	13.13M -76.2%	16.24M 23.6%	20.68M 27.3%	19.74M -4.5%	37.04M 87.6%	86.59M 133.8%	87.99M 1.6%	126.47M 43.7%	152.12M 20.3%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	194.91M 56.4%	133.65M -31.4%	149.69M 12.0%	143.38M -4.2%	164.95M 15.0%	174.99M 6.1%	186.72M 6.7%	219.93M 17.8%	215.41M -2.1%	247.48M 14.9%	230.9M -6.7%	234.41M 1.5%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	194.91M 56.4%	133.5M -31.5%	144.64M 8.4%	142.13M -1.7%	164.86M 16.0%	173.61M 5.3%	183.79M 5.9%	212.12M 15.4%	207.03M -2.4%	225.07M 8.7%	210.98M -6.3%	214.21M 1.5%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-194.29M -	-128M -	-89.4M -	-129M -	-148.62M -	-152.94M -	-164.05M -	-175.08M -	-120.44M -	-137.08M -	-84.52M -	-62.09M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-219.19M -	-195.57M -	-147.93M -	-138.94M -	-155.98M -	-191.27M -	-165.99M -	-177.78M -	-122.04M -	-140.24M -	-88.58M -	-66.42M -
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-219.19M -	-195.57M -	-147.93M -	-138.94M -	-155.98M -	-191.27M -	-165.99M -	-177.78M -	-122.04M -	-140.24M -	-88.58M -	-66.42M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-2.72 -	-2.28 -	-1.53 -	-1.42 -	-1.46 -	-1.75 -	-1.5 -	-1.56 -	-1.02 -	-1.17 -	-0.73 -	-0.54 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-2.72 -	-2.28 -	-1.53 -	-1.42 -	-1.46 -	-1.75 -	-1.5 -	-1.56 -	-1.02 -	-1.17 -	-0.73 -	-0.54 -